Copyright
©The Author(s) 2022.
World J Gastroenterol. Jun 28, 2022; 28(24): 2689-2704
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2689
Published online Jun 28, 2022. doi: 10.3748/wjg.v28.i24.2689
Figure 5 Apoptosis distribution analysis in nonsilenced AGS cells, cells with TNFR1 downregulated (shTNFR1), and cells with TNFR2 downregulated (shTNFR2).
A: Cells without additional treatment (control); B: Cells treated with the Helicobacter pylori extract; A and B: Representative images of the cell distribution and percentage in the different quadrants indicating viable cells (Annexin V-/PI-) in the lower left, early apoptotic cells (Annexin V+/PI-) in the lower right and late apoptotic cells (Annexin V+/PI+) in the upper right; C and D: Histogram bars represent the mean ± SD from three independent trials for early (C) and late (D) apoptosis. Statistically significant difference: aP < 0.05; bP < 0.01. eHP: Helicobacter pylori extract.
- Citation: Rossi AFT, da Silva Manoel-Caetano F, Biselli JM, Cabral ÁS, Saiki MFC, Ribeiro ML, Silva AE. Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells. World J Gastroenterol 2022; 28(24): 2689-2704
- URL: https://www.wjgnet.com/1007-9327/full/v28/i24/2689.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i24.2689